Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iftekhar Mahmood

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Drugs in R&D|November 5, 2020
A GFR-Based Method to Predict the Effect of Renal Impairment on the Exposure or Clearance of Renally Excreted Drugs: A Comparative Study Between a Simple GFR Method and a Physiologically Based Pharmacokinetic ModelIftekhar Mahmood
Antibodies (Basel, Switzerland)|January 12, 2021
Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human ClearanceIftekhar Mahmood
Antibodies (Basel, Switzerland)|September 25, 2021
A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond MonkeyIftekhar Mahmood
Drug Discovery Today. Technologies|July 2, 2014
Methods to determine pharmacokinetic profiles of therapeutic proteinsIftekhar Mahmood
Drugs in R&D|December 11, 2019
Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and AdultsIftekhar Mahmood
Journal of Clinical and Translational Research|December 15, 2022
A comparison of different methods for the first-in-pediatric dose selectionIftekhar Mahmood
Expert Opinion on Drug Metabolism & Toxicology|July 13, 2018
Misconceptions and issues regarding allometric scaling during the drug development processIftekhar Mahmood
Drug Metabolism and Drug Interactions|July 31, 2004
Impact of truncated area under the curve on failed bioequivalence studies: a computer simulation analysisIftekhar Mahmood
Drug Metabolism and Drug Interactions|July 31, 2004
Estimation of absorption rate constant (ka) following oral administration by Wagner-Nelson, Loo-Riegelman, and statistical moments in the presence of a secondary peakIftekhar Mahmood
American Journal of Therapeutics|July 9, 2016
Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived ProductsIftekhar Mahmood
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Drugs in R&D|November 5, 2020
A GFR-Based Method to Predict the Effect of Renal Impairment on the Exposure or Clearance of Renally Excreted Drugs: A Comparative Study Between a Simple GFR Method and a Physiologically Based Pharmacokinetic ModelIftekhar Mahmood
Antibodies (Basel, Switzerland)|January 12, 2021
Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human ClearanceIftekhar Mahmood
Antibodies (Basel, Switzerland)|September 25, 2021
A Single Animal Species-Based Prediction of Human Clearance and First-in-Human Dose of Monoclonal Antibodies: Beyond MonkeyIftekhar Mahmood
Drug Discovery Today. Technologies|July 2, 2014
Methods to determine pharmacokinetic profiles of therapeutic proteinsIftekhar Mahmood
Drugs in R&D|December 11, 2019
Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and AdultsIftekhar Mahmood
Journal of Clinical and Translational Research|December 15, 2022
A comparison of different methods for the first-in-pediatric dose selectionIftekhar Mahmood
Expert Opinion on Drug Metabolism & Toxicology|July 13, 2018
Misconceptions and issues regarding allometric scaling during the drug development processIftekhar Mahmood
Drug Metabolism and Drug Interactions|July 31, 2004
Impact of truncated area under the curve on failed bioequivalence studies: a computer simulation analysisIftekhar Mahmood
Drug Metabolism and Drug Interactions|July 31, 2004
Estimation of absorption rate constant (ka) following oral administration by Wagner-Nelson, Loo-Riegelman, and statistical moments in the presence of a secondary peakIftekhar Mahmood
American Journal of Therapeutics|July 9, 2016
Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived ProductsIftekhar Mahmood
Pageof 9